MedPass helps clients obtain visibility on the reimbursement landscape for their products, in various EU markets. We perform in depth, customized, product specific research to determine any funding and reimbursement opportunities. The landscape aims to provide an overview of the reimbursement mechanism for the device.
Our objective is to anticipate immediate opportunities for the device and identify potential pathways for long-term opportunities.
MedPass access and reimbursement strategies.
Features of our customized reimbursement services include:
- In-depth, customized Reimbursement Roadmaps for key EU markets, including short term strategies. To obtain reimbursement by identification of existing coverage for competing products, and identification of fast track reimbursement procedures for innovative technologies.
- KOL and payer meetings and advisory boards.
- Health Technology Assessment (HTA) dossier preparation and submission.
- Health Economic Model adaptation for EU markets.
- Systematic Literature Reviews, evidence assessments and development of value propositions.
We provide our clients with the most valuable advice before implementing the clinical protocol. As a CRO, MedPass help clients in building the clinical development strategies all along the process.
Obtain visibility regarding the targeted countries (early opportunities, existing codes and payments or innovation funding programs).
Assess decision-makers’ expectations (through benchmark, literature, guidelines and HTA reviews) with regards to the device’s available information.
Determine what actions need to be taken to secure longer term reimbursement, successful market access and countries prioritization.
Confirm reimbursement strategy and requirements, assistance for the slide deck preparation, debriefing session to implement reimbursement actions.
Preparation, review and validation of the application for reimbursement or funding programs purposes.
Health Economic Model adaptation for EU markets, cost-effectiveness and budget impact analysis.
We are highly experienced in developing and validating reimbursement roadmaps, for a broad range of technologies covering all therapeutic areas. MedPass assist manufacturers to insure/ensure that sudy design will meet reimbursement requirements in certain key markets.